Diet and Lifestyle for Vomiting on Mounjaro (tirzepatide for T2D): What Actually Works

Why vomiting shows up on Mounjaro

Tirzepatide is a once-weekly subcutaneous injection that activates both GIP and GLP-1 receptors, and vomiting is one of its most common adverse reactions in the Mounjaro label [1]. The label states that tirzepatide delays gastric emptying, that the delay is largest after the first dose, and that it diminishes over time [1].

In the label's pooled placebo-controlled trials in adults with type 2 diabetes (SURPASS-1 and SURPASS-5; 235 patients on placebo, 237 on 5 mg, 240 on 10 mg, 241 on 15 mg; mean exposure 36.6 weeks), vomiting was reported by 2% on placebo and by 5%, 5% and 9% at 5, 10 and 15 mg [1].

What the label says about dose escalation

Mounjaro starts at 2.5 mg once weekly. If additional blood sugar control is needed, the dose can increase in 2.5 mg steps after at least 4 weeks on the current dose, a schedule the label says to follow to reduce the risk of gastrointestinal adverse reactions [1]. The maximum is 15 mg once weekly in adults and 10 mg once weekly in patients 10 years and older [1].

The label adds that most reports of nausea, vomiting and diarrhea came during dose escalation and decreased over time, and that Mounjaro is not recommended in patients with severe gastroparesis [1].

Is there a diet that works for Mounjaro vomiting?

The Mounjaro label does not give a dietary measure for vomiting. It says Mounjaro can be injected at any time of day, with or without meals [1].

What to watch for while vomiting

Dehydration and kidney injury. The label warns about acute kidney injury due to volume depletion, mostly in patients who had gastrointestinal reactions leading to dehydration such as nausea, vomiting or diarrhea. It says to monitor renal function in patients reporting reactions that could lead to volume depletion, especially during initiation and dose escalation [1].

Pancreatitis. The label says to watch for signs of acute pancreatitis, which may include persistent or severe abdominal pain sometimes radiating to the back, with or without nausea or vomiting. If pancreatitis is suspected, the label says to discontinue Mounjaro and initiate appropriate management [1].